US$ 22.78
bpc-157 tb-500 stack synergy / Blend (Dual Peptide) BPC-157 + TB-500 Research Compound
Description
Manufacturing standards stated by the company

Gastrointestinal symptoms are very common, with nausea affecting approximately 1 in 3 patients in clinical trials

Results vary by individual, and no specific outcomes are guaranteed

Capsules may serve as a convenient but underwhelming introduction to the peptide

We do not require insurance
Combining advanced diagnostics, functional medicine principles, and results-driven therapies, we offer tailored interventions designed to optimise your energy, sharpen mental clarity, balance hormones, and future-proof your wellbeing